You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 59 results
 
  • Record 1 TO 59

  1. Heptax for Alcoholic Liver Disease

    SBC: CARDAX PHARMACEUTICALS, INC.            Topic: NIAAA

    DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) is caused by excessive long term consumption of alcohol via increased oxidative stress, reduction of oxygen to liver tissue (hypoxia), altered fat metabolism, increased pro-inflammatory signaling molecules (or cytokines), and increased inflammation. ALD begins with increased fat deposit in the liver. With continued excessive alcoho ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health

  2. Automated, portable, concurrent, WMD detection system

    SBC: Concurrent Analytical, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of this project is the development of a fully automated, wireless ethernet capable, near realtime, field deployable immunoassay-based analysis system for the concurrent, ultra low-level detection of biowarfare agents in air or water by using innovations in surface enhanced Raman scattering (SERS) and related supporting materials and hardware. A ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  3. N/A

    SBC: CYANOTECH CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  4. N/A

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  5. N/A

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health

  6. N/A

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    N/A

    SBIR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health

  7. Development of a MSP1-p42 Subunit Vaccine for Malaria

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    DESCRIPTION (provided by the applicant): Malaria is a tropical parasitic disease that poses a significant health threat to much of the world. Each year, approximately 500 million people become infected and more than 2 million die. There is a great need to control the spread of this disease. One of the main focuses of malaria vaccine development has been the on use o ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health

  8. Development of a MSP1-p42 Subunit Vaccine for Malaria

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    DESCRIPTION (provided by the applicant): Malaria is a tropical parasitic disease that poses a significant health threat to much of the world. Each year, approximately 500 million people become infected and more than 2 million die. There is a great need to control the spread of this disease. One of the main focuses of malaria vaccine development has been the on use o ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health

  9. TARGETED PRODRUGS OF 9-AMINOCAMPTOTHECIN

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    DESCRIPTION (Adapted from the application): The goal of this project is to produce a water-soluble anticancer prodrug and an antibody-enzyme conjugate for use in Antibody-Directed Enzyme Prodrug Therapy (ADEPT). The prodrug will be a derivative of 9-aminocamptothecin (9AC), a lipophilic topoisomerase I inhibitor that is not subject to P-glycoprotein resistance. Though it ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health

  10. OLIGONUCLEOTIDE LIGANDS FOR PESTICIDE DETECTION IN FOODS

    SBC: HAWAII BIOTECH, INC.            Topic: N/A

    DESCRIPTION (applicant's abstract): The detection of pesticide residue in foods is a significant issue in food safety. Current analytical methods, however, involve complicated and expensive equipment that requires skilled operators and cannot be readily applied to field applications. Antibody based methods are possible alternatives to current pesticide detection methods ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government